Bath & Body Works (NYSE:BBWI) Stock Price Up 4.9% – Here’s Why

Bath & Body Works, Inc. (NYSE:BBWI)’s stock price traded up 4.9% during mid-day trading on Monday . The company traded as high as $40.44 and last traded at $40.49. 2,439,409 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 3,274,427 shares. The stock had previously closed at $38.59.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Telsey Advisory Group reaffirmed an “outperform” rating and set a $43.00 price objective on shares of Bath & Body Works in a report on Thursday. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $41.00 to $47.00 in a report on Tuesday, February 18th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $42.00 to $48.00 in a report on Friday, January 10th. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Six equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $44.19.

Bath & Body Works Trading Up 3.6 %

The firm’s 50-day moving average price is $37.70 and its two-hundred day moving average price is $33.90. The stock has a market cap of $8.66 billion, a PE ratio of 9.75, a PEG ratio of 0.96 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the business posted $0.48 EPS. On average, analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works’s payout ratio is currently 19.51%.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors have recently bought and sold shares of BBWI. Golden State Wealth Management LLC purchased a new stake in shares of Bath & Body Works during the 4th quarter valued at $26,000. SRS Capital Advisors Inc. raised its stake in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after buying an additional 329 shares during the last quarter. True Wealth Design LLC boosted its holdings in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after acquiring an additional 1,054 shares in the last quarter. UMB Bank n.a. boosted its holdings in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after acquiring an additional 431 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.